A groundbreaking treatment is offering hope to individuals who have struggled with vocal impairments due to severe injuries or illnesses. By utilising platelet-rich plasma (PRP) derived from the patient’s own blood, this innovative therapy is rejuvenating damaged vocal cords and restoring the ability to speak and sing.
A Personal Journey to Recovery
David Metherell, a 45-year-old critical care nurse, is one of the first beneficiaries of this pioneering treatment. From a tender age of nine months, he faced a significant challenge when he contracted a rare strain of human papillomavirus (HPV) that severely damaged his vocal cords. Over the years, he underwent 21 surgeries, yet these procedures left him with a permanently hoarse voice and a profound inability to express himself fully.
“I’ve never been able to sing, I’ve never been able to shout – I’ve just been limited in so many ways,” Metherell shared with the BBC, reflecting on the impact his condition had on his life. However, the recent injection therapy has been nothing short of transformative, allowing him to read bedtime stories to his son—an experience that had long eluded him.
How the Treatment Works
The treatment, administered at the ear, nose and throat (ENT) clinic at Guy’s Hospital, employs PRP injections to stimulate healing in the vocal cords. This technique has previously been utilised in NHS clinics for treating injuries in knees and tendons, but its application to vocal cords is a novel development.
Consultant Shiying Hey, who leads the treatment programme, has reported encouraging results from the initial trials. To date, ten patients have undergone the procedure, and all have noted improvements in their vocal abilities. “The use of the patient’s own blood makes this method more cost-effective compared to other treatments,” she explained, highlighting its potential for broader accessibility.
Following a series of three injections, Metherell has found himself able to communicate effectively in social and professional settings, a significant milestone for someone who had long struggled with vocal limitations. Previous studies indicate that the benefits of PRP injections can manifest within two years; one such study published in the *Journal of Voice* reported that over 70 per cent of participants experienced moderate to significant vocal improvements after undergoing similar treatment.
Advancements in Speech Technology
While PRP injections mark a significant advancement in rehabilitative therapies for vocal cord damage, researchers are also exploring other innovative technologies to aid speech. The University of Cambridge has developed a device called Revoice, which leverages artificial intelligence to assist individuals with speech impairments. This technology eliminates the need for invasive brain implants, enabling users to communicate more naturally.
Revoice operates as a flexible choker worn around the neck, capturing subtle signals from the throat muscles and converting them into words. In a small trial involving five patients with dysarthria—a condition that affects speech post-stroke—the device achieved a remarkable accuracy rate, misidentifying only 4.2 per cent of words and 2.9 per cent of sentences.
Current speech-assist technologies often require laborious input methods, such as typing letters or relying on eye-tracking systems, making advancements like Revoice particularly promising.
Why it Matters
The introduction of PRP injection therapy and emerging technologies like Revoice signify a monumental leap forward in the field of speech rehabilitation. For individuals like David Metherell, these advancements are not merely medical treatments; they represent a reclamation of identity and the ability to communicate—fundamental aspects of human experience. As research continues and these therapies become more widely available, the potential to restore voices—and, by extension, lives—offers hope to countless individuals enduring the silence of vocal impairments.
